Hyperfine, Inc. (HYPR)
| Market Cap | 128.08M |
| Revenue (ttm) | 13.56M |
| Net Income (ttm) | -35.57M |
| Shares Out | 98.52M |
| EPS (ttm) | -0.43 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 422,057 |
| Open | 1.300 |
| Previous Close | 1.300 |
| Day's Range | 1.280 - 1.330 |
| 52-Week Range | 0.533 - 2.220 |
| Beta | 1.06 |
| Analysts | Strong Buy |
| Price Target | 1.45 (+11.54%) |
| Earnings Date | May 12, 2026 |
About HYPR
Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departments, and comprehensive and primary stroke accredi... [Read more]
Financial Performance
In 2025, Hyperfine's revenue was $13.56 million, an increase of 5.22% compared to the previous year's $12.89 million. Losses were -$35.57 million, -12.64% less than in 2024.
Financial StatementsAnalyst Forecast
According to 3 analysts, the average rating for HYPR stock is "Strong Buy." The 12-month stock price target is $1.45, which is an increase of 11.54% from the latest price.
News
Hyperfine, Inc. to Announce First Quarter 2026 Financial Results on May 12, 2026
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine to report financial results for Q1 2026 on Tue., May 12, 2026. Management will host corresponding conference call at 1:30 PM PT/4:30 PM ET.
Hyperfine Receives CE and UKCA Marks for Next-Generation Swoop® System and Latest Advancement in Optive AI™ Software
GUILFORD, Conn.--(BUSINESS WIRE)--Next-gen Swoop system and latest Optive AI software receive CE & UKCA marks, bringing Hyperfine's most advanced portable MRI tech to European markets.
Horizon Technology Finance Provides $40 Million Loan Facility to Hyperfine
FARMINGTON, Conn.--(BUSINESS WIRE)--Horizon Technology Finance Corporation (NASDAQ: HRZN) (“Horizon”) (the “Company”), an affiliate of Monroe Capital, today announced it has provided a $40 million loa...
Hyperfine Earnings Call Transcript: Q4 2025
Q4 2025 revenue surged 128% year-over-year, driven by strong adoption of the next-gen Swoop system and Optive AI software, with robust growth in hospitals, neurology offices, and international markets. 2026 guidance projects 55% revenue growth and continued margin expansion.
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic ...
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI syste...
Hyperfine Announces Publication of Breakthrough Clinical Data Demonstrating the Swoop® System's Enhanced Stroke Detection Capabilities
GUILFORD, Conn.--(BUSINESS WIRE)--Strong evidence supports the use of AI-powered portable MRI for stroke detection in multiple clinical settings, including the emergency department.
Hyperfine Announces NEURO PMR Study Results Showing High Diagnostic Value and Superior Patient Experience in Neurology Clinics
GUILFORD, Conn.--(BUSINESS WIRE)--Results from the NEURO PMR study, presented by Dr. Laszlo Mechtler at the ASN Annual Meeting in San Juan, Puerto Rico, on January 16, 2026.
Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents
GUILFORD, Conn.--(BUSINESS WIRE)--Prospective study is designed to evaluate the feasibility and visualization benefits of contrast-enhanced ultra-low-field portable MRI.
Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI syste...
Hyperfine Announces First Peer-Reviewed Publication Demonstrating Significant Economic Benefits of Using the Swoop® AI-Powered Portable MRI System in Acute Hospital Care
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine announces the first analysis showing the AI-powered Swoop® portable MRI system reduces hospital costs and improves economics in acute care.
Hyperfine Announces Regulatory Approval of the Swoop® System in India
GUILFORD, Conn.--(BUSINESS WIRE)--Swoop® portable MRI system receives CDSCO approval in India, expanding access to advanced brain imaging in a large, fast-growing healthcare market.
Hyperfine Announces FDA Clearance of the First Optive AI™ Software Update with Advanced Diffusion Imaging Capability, Focused on Enhancing Stroke Detection with the Swoop® System
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine secures FDA clearance for new DWI sequence, significantly expanding the Swoop® system's clinical capabilities in acute neurological care.
Hyperfine Transcript: Piper Sandler 37th Annual Healthcare Conference
A first-mover in portable brain MRI, the company leverages AI-driven innovation and a strong patent portfolio to expand across hospital, office, and international markets. Recent FDA clearance and commercial launches drive growth, with Q3 revenue up 27%.
Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine announces plans to present at the upcoming Piper Sandler 37th Annual Healthcare Conference on Thursday, December 4th at 8:10 AM ET.
Hyperfine Awarded $3.7 Million Grant to Advance Global Brain Health
GUILFORD, Conn.--(BUSINESS WIRE)--$3.7M grant supports expanded use of portable MRI to evaluate brain development and guide targeted health interventions in underserved communities.
Hyperfine Earnings Call Transcript: Q3 2025
Q3 2025 saw 27% sequential revenue growth, record gross margin, and reduced cash burn, driven by next-gen product launches and strong demand across hospital, office, and international markets. Guidance for Q4 and full-year 2025 was raised, with a strengthened capital position and cash runway into H2 2027.
Hyperfine, Inc. Reports Third Quarter 2025 Financial Results
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine today announced third quarter 2025 financial results and provided a business update.
Hyperfine, Inc. to Announce Third Quarter 2025 Financial Results on November 13, 2025
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI syste...
Hyperfine Announces First Patients Enrolled in PRISM PMR to Evaluate the Use of Next-Generation Swoop® System in the Operating Room Setting
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine launches study to assess Swoop® System use in neurosurgical ORs, advancing accessible brain MRI across care settings.
Hyperfine Announces Pricing of $17.5 Million Public Offering
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR) (“Hyperfine” or the “Company”) today announced it has priced its previously announced underwritten public offering of 14,000,000 shares...
Hyperfine Announces Proposed Public Offering
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR) (“Hyperfine” or the “Company”) today announced that it has commenced an underwritten public offering of its Class A common stock or, in...
Hyperfine Reports Preliminary, Unaudited Results for Third Quarter 2025, Signaling Strong Business Momentum Following the Launch of the Next Generation Swoop® System
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI syste...
Hyperfine Swoop® System Referenced in France's Largest Public Hospital Procurement Body to Facilitate Nationwide Purchases of Portable MRI Technology
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine Swoop® system, via partner UpCare, earns national referencing from UniHA, France's top hospital purchasing cooperative.
Hyperfine Launches PULSE Platform to Accelerate Adoption and Innovation of AI-Powered Portable MRI
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine launches a subscription-based platform designed to empower researchers and developers advancing access and innovation in portable MRI.